蘇勇曄主治醫師-論文

PUBLICATIONS
  1. SU YY, CHIANG NJ, WU CC, CHEN LT*. Primary gastrointestinal stromal tumor of the liver in an anorectal melanoma survivor: A case report. Oncology Letters. 2015;10(4):2366-2370. doi:10.3892/ol.2015.3561. [IF:1.482 ONCOLOGY – SCIE 187/230]
  2. Su YY†, Liu YS†, Chao YJ, Chiang NJ, Yen CJ, Tsai HM*. Percutaneous Computed Tomography-Guided Coaxial Core Biopsy for the Diagnosis of Pancreatic Tumors. J Clin Med. 2019 Oct 5;8(10). pii: E1633. doi: 10.3390/jcm8101633. [IF:5.688 MEDICINE, GENERAL & INTERNAL – SCIE 15/160]
  3. Yung-Yeh Su†, Nai-Jung Chiang†, Hui-Jen Tsai, Chia-Jui Yen, Yan‐Shen Shan*, Li‐Tzong Chen. The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in an Asian population. Sci Rep. 2020 May 4;10(1):7420. doi: 10.1038/s41598-020-64421-6. [IF:4.011 MULTIDISCIPLINARY SCIENCES – SCIE 15/69]
  4. Nai-Jung Chiang, Ming-Huang Chen, Shih-Hung Yang, Chiun Hsu, Chia-Jui Yen, Hsiao-Hui Tsou, Yung-Yeh Su, Jen-Shi Chen, Yan-Shen Shan, Li-Tzong Chen. Multicentre, Phase II Study of Gemcitabine and S-1 in Patients With Advanced Biliary Tract Cancer: TG1308 Study. Liver Int. 2020 Oct;40(10):2535-2543. [IF:5.542 GASTROENTEROLOGY & HEPATOLOGY – SCIE 16/84]
  5. Chia-Yu Chen, Shih-Hsin Liang, Yung-Yeh Su, Nai-Jung Chiang, Hui-Ching Wang, Chang-Fang Chiu, Li-Tzong Chen, Li-Yuan Bai. Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan. PLoS One. 2020 Dec 29;15(12):e0244487. doi: 10.1371/journal.pone.0244487. [IF:2.740 MULTIDISCIPLINARY SCIENCES – SCIE 27/71]
  6. Yung-Yeh Su, Chia-Chen Li, Yih-Jyh Lin*, Chiun Hsu*. Adjuvant versus Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: Clinical and Immunologic Perspectives. Semin Liver Dis. 2021 Aug;41(3):263-276. [IF:6.115 GASTROENTEROLOGY & HEPATOLOGY SCIE 22/92]
  7. Yung-Yeh Su†, Yen-Feng Chiu†, Chung-Pin Li, Shih-Hung Yang, Johnson Lin, Shyh-Jer Lin, Ping-Ying Chang, Nai-Jung Chiang, Yan-Shen Shan*, Hui-Ju Ch’ang*, Li-Tzong Chen*. A Phase II Randomized Trial of Induction Chemotherapy followed by Concurrent Chemo-radiotherapy in Locally Advanced Pancreatic Cancer: the Taiwan Cooperative Oncology Group T2212 study. Br J Cancer. 2021 Dec 17. doi: 10.1038/s41416-021-01649-7. Online ahead of print. [IF:7.640 ONCOLOGY SCIE 39/242]

ABSTRACTS
  1. Su YY, Chiang NJ, Lin YJ, Shan YS, Chen LT*. AB060. P-31. Complete response to immunotherapy in cholangiocarcinoma with peritoneal metastases and high PD-L1 expression: a case report. Hepatobiliary Surg Nutr. 2019 Mar;8(Suppl 1):AB060. doi: 10.21037/hbsn.2019.AB060.
  2. Yung-Yeh Su, Yih-Jyh Lin, Chin-Fu Hsiao, Da-Liang Ou, San-Chi Chen, Yao-Ming Wu, Wei-Chen Lee, Jiunn-Chang Lin, Chia-Lang Hsu, Ming-Chi Ho, Li-Chun Lu, Tsung-Han Wu, Shiue-Wei Lai, Ying-Jui Chao, Tsung-Ching Chou, Chia-Jui Yen, Li-Tzong Chen, Yen-Shan Shen, Ann-Lii Cheng, Chiun Hsu. Nivolumab plus ipilimumab (N+I) as neoadjuvant therapy for potentially resectable hepatocellular carcinoma (HCC). Annals of Oncology, 2021. 32: p. S141.
Share Button

Comments are closed.